Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Cuomo says restaurants in CNY, other phase 2 regions can reopen for outdoor dining Thursday
ALBANY, N.Y. — Gov. Andrew Cuomo on Wednesday announced that outdoor dining at restaurants will be permitted in Central New York and six other regions

SYRACUSE, N.Y. — Syracuse University’s leader says he doesn’t believe it’s possible to hold an in-person commencement ceremony for the Class of 2020 until after

Onondaga County warns of possible COVID-19 exposure at area T-Mobile store
CLAY, N.Y. — The Onondaga County Health Department has confirmed that an employee at the T-Mobile store at 5133 W. Taft Road has tested positive

SUNY Chancellor stepping down, to lead Ohio State University
ALBANY, N.Y. — SUNY Chancellor Kristina Johnson is stepping down to become the next president of the Ohio State University, effective Sept. 1. State University

MVCC freezes tuition as part of 2020-21 budget
UTICA, N.Y. — The newly approved budget for Mohawk Valley Community College (MVCC) includes a freeze on tuition and student fees and no layoffs. The

ConMed to pay quarterly dividend of 20 cents a share on July 6
UTICA — ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share. The dividend is payable on July 6 to all shareholders of record as of June 15. ConMed provides surgical devices and equipment for minimally invasive procedures. The
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
UTICA — ConMed Corp. (NYSE: CNMD), a Utica–based surgical-device maker, recently announced that its board of directors has declared a quarterly cash dividend of 20 cents a share.
The dividend is payable on July 6 to all shareholders of record as of June 15.
ConMed provides surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed reported adjusted net income of more than $15 million, or 51 cents per share, in the first quarter, down from adjusted net income of more than $16 million, or 57 cents, in the same period in 2019. The company said it incurred costs in both 2019 and 2020 related to its 2019 acquisition of Buffalo Filter, LLC.
Chemung Financial to pay quarterly dividend of 26 cents on July 1
ELMIRA — Chemung Financial Corp. (NASDAQ: CHMG) recently announced that its board of directors has approved a quarterly cash dividend of 26 cents a share. The dividend is payable on July 1 to common stock shareholders of record as of the close of business on June 17. At the banking company’s current stock price, the
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
ELMIRA — Chemung Financial Corp. (NASDAQ: CHMG) recently announced that its board of directors has approved a quarterly cash dividend of 26 cents a share.
The dividend is payable on July 1 to common stock shareholders of record as of the close of business on June 17.
At the banking company’s current stock price, the dividend yields about 3.95 percent annually.
Elmira–based Chemung Financial is a $1.8 billion financial services holding company that operates 32 branches through its main subsidiary, Chemung Canal Trust Company, a full-service community bank with full trust powers.
Established in 1833, Chemung Canal Trust says it is the oldest locally owned and managed community bank in New York state. Chemung Financial is also the parent of CFS Group, Inc., a financial-services subsidiary offering mutual funds, annuities, brokerage services, tax-preparation services and insurance, as well as Chemung Risk Management, Inc., an insurance company based in Nevada.

Madison County seeks developers for state canals initiative project in Canastota
CANASTOTA — Interested developers have until July 21 to respond to Madison County’s request for qualifications (RFQ) on a project to turn 160 Center St. in Canastota into a “canalside pocket neighborhood.” The project is part of the state’s Reimagine the Canals initiative. The county released a request for qualifications (RFQ) in partnership with the
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
CANASTOTA — Interested developers have until July 21 to respond to Madison County’s request for qualifications (RFQ) on a project to turn 160 Center St. in Canastota into a “canalside pocket neighborhood.”
The project is part of the state’s Reimagine the Canals initiative.
The county released a request for qualifications (RFQ) in partnership with the New York State Canal Corporation and the New York Power Authority, per a May 26 news release.
Respondents to the RFQ should demonstrate their experience and capacity to construct and complete the project.
The project seeks to “showcase” canalside living and be a pilot project for the New York State Canal system, Madison County said.
The developer selected will partner with Madison County on this project. It’s part of Reimagine the Canals, an Erie Canal bicentennial initiative and reinvestment campaign.
Madison County was the winner of the state’s Reimagine the Canals competition, securing $1.5 million to directly support the development of this canalside pocket neighborhood.
Madison County currently owns the site that is the location for the canalside pocket neighborhood project.
“It is a 2.5-acre site with 250 feet of Erie Canal frontage and is in walking distance of Canastota’s downtown,” Jamie Kowalczk, assistant director of the Madison County Planning Department, said. “By linking new desirable housing choices to the Erie Canal’s one-of-a-kind trail and waterway system, we are hoping to retain and attract residents to our community’s downtown.”
The preferred redevelopment of the site will include a mix of housing, creative layout and site design, and reactivation of the canal waterfront.
“The vision for the project is to leverage the … brand and amenities of the Erie Canal and combine it with quality design to create a unique canalside living experience,” said Kowalczk “And now we are looking forward to bringing in a partner developer to build the project.”
To view bid details, visit: https://www.madisoncounty.ny.gov/bids.aspx
For more information on the project visit www.CanalsideCanastota.com, Madison County said.

Oneida County announces additional possible public exposure to virus at area stores
UTICA, N.Y. — Oneida County officials on Tuesday reported recent, possible public exposure to the coronavirus at area retailers including Rite Aid in New Hartford

WellNow’s CNY clinics conduct over 4,400 COVID-19 & antibody tests in first 2 weeks
WellNow Urgent Care has now been offering for more than two weeks, two types of COVID-19 testing at its Central New York clinics. The first type is a molecular polymerase chain reaction (PCR) or nasal swab test, which is used to diagnose current COVID-19 infections. The second test is a blood antibody serology test that
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
Click here to purchase a paywall bypass link for this article.
WellNow Urgent Care has now been offering for more than two weeks, two types of COVID-19 testing at its Central New York clinics.
The first type is a molecular polymerase chain reaction (PCR) or nasal swab test, which is used to diagnose current COVID-19 infections. The second test is a blood antibody serology test that is used to detect recent or past exposure to the coronavirus.
WellNow provided CNYBJ testing data for the two-week period from May 6 through May 19. The offices involved performed a total of 3,790 antibody tests and a total of 640 molecular tests. The average antibody tests per day for Central New York clinics was 271 in the period, and the average number of molecular tests per day at those same clinics was 46, according to the WellNow data.
“Bringing both types of COVID-19 testing to our communities in Central New York is a top priority right now,” Dr. John Radford, president of WellNow Urgent Care, said in a statement, when WellNow launched the testing. “As New York [starts reopening], providing all our communities with answers to their COVID-19 questions is as much our responsibility as is making sure all our centers remain a safe and welcoming place for all urgent care needs.”
Testing is available at WellNow’s Central New York offices that include Auburn, Cicero, Clay, DeWitt, Fairmount, Fayetteville, Liverpool, Oneida, Oswego, and Rome. The tests are available seven days a week with no appointments needed.
About the tests
The molecular (PCR) test, like a flu test, requires a nasopharyngeal swab to determine if a patient has COVID-19. Antibody testing uses a blood sample to determine the presence of antibodies in response to a recent or past COVID-19 infection. Additionally, antibody testing can suggest if an individual may have some protection from the virus and help identify potential plasma donors.
All patients are screened in their car, provided a mask, and brought directly to a private patient room for further evaluation and testing. Both tests are “highly accurate,” and the two accepted forms of COVID-19 screening used by health providers, and validated by the U.S. Food and Drug Administration, WellNow says.
Labs are overnighted, with results returned three to five days later through an online portal located at www.mybostonheart.com.
Besides the testing, WellNow locations continue to provide treatment for non-life-threatening injuries and illnesses, such as sprains, strains, colds and the flu, while also providing on-site X-rays, lab testing, and physicals. Patients are treated on a walk-in basis.
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.